XML 46 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
12 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2013
Cash Flows From Operating Activities:      
Net (loss) income $ (3,849,773) $ (2,490,145) $ 257,487
Adjustments to reconcile net (loss) income to net cash used in by operating activities:      
Depreciation and Amortization 768,163 $ 879,329 $ 901,407
Impairment of intangibles 1,495,703    
Bad debt expense 186,780 $ 186,740 $ 144,617
Stock compensation expense 2,760,329 1,719,375 $ 843,645
Stock issued for charity 157,950 96,900  
Decrease (increase) in:      
Trade Receivables 710,302 (661,357) $ (1,859,987)
Prepaids and other assets (501,955) (20,747) (226,552)
Increase (decrease) in:      
Accounts payable (49,296) 84,634 102,809
Accrued liabilities 136,517 49,252 (8,357)
Deferred revenue (107,123) 63,485 (304,133)
Net cash provided by (used in) operating activities 1,707,597 $ (92,534) $ (149,064)
Cash Flows From Investing Activities:      
Payments received on notes receivable 300,000    
Net cash received in acquisition 22,119    
Purchase of property and equipment (369,536) $ (459,230) $ (445,744)
Cash advanced on Note Receivable $ (2,559,460) (1,200,000)  
Cash from sale of property and equipment   6,505  
Net cash used in investing activities $ (2,606,877) (1,652,725) $ (445,744)
Cash Flows From Financing Activities:      
Proceeds from issuance of stock 7,606,384 $ 1,493,818 $ 4,162,920
Net increase in lines of credit 1,300,000    
Proceeds from employee stock plans 203,211 $ 153,875 $ 156,741
Proceeds from issuance of notes payable $ 172,795 338,287 $ 176,797
Proceeds from exercise of options and warrants   $ 633,454  
Preferred stock redemption $ (7,500)   $ (21,720)
Dividends paid (157,147) $ (586,999) (503,311)
Payments on notes payable and capital leases (245,450) (551,202) (866,210)
Net cash provided by financing activities 8,872,293 1,481,233 3,105,217
Net increase (decrease) in cash and cash equivalents 7,973,013 (264,026) 2,510,409
Cash and cash equivalents at beginning of period 3,352,559 3,616,585 1,106,176
Cash and cash equivalents at end of period $ 11,325,572 3,352,559 $ 3,616,585
Supplemental Disclosure of Cash Flow Information:      
Cash paid for income taxes   6,634  
Cash paid for interest $ 80,534 $ 75,343 $ 142,491
Supplemental Disclosure of Non-Cash Investing and Financing Activities:      
Preferred stock to pay accrued liabilities 300,000    
Common stock to pay accrued liabilities 1,860,191 $ 1,107,698 $ 786,343
Dividends accrued on preferred stock 568,821 $ 617,891 911,580
Dividends paid with preferred stock $ 442,002   501,060
Conversion of accounts receivable into notes receivable     $ 1,622,863
Series B restructure $ 2,141,980    
Fair value of assets and liaiblities acquired:      
Receivables 152,340    
Prepaid expenses 17,500    
Customer relationships 2,006,951    
Goodwill 15,385,002    
Accounts payable (128,126)    
Deferred revenue (598,232)    
Net assets acquired $ 16,835,435    
Common stock issued 10,821,897    
Receivables eliminated in consolidation $ 6,035,657    
Cash received in acquisition $ 22,119